These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2680728)

  • 41. Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma.
    Landgraf RG; Nossi DF; Sirois P; Jancar S
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):163-72. PubMed ID: 17923399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prostaglandins and collagen metabolism in chronic liver diseases].
    Iagoda AV; Topchieva GIu; Geĭvandova NI; Markova IV
    Klin Med (Mosk); 1993; 71(3):51-5. PubMed ID: 8015221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of prostaglandins, leukotrienes and essential fatty acids in the pathogenesis of the complications associated with diabetes mellitus.
    Mikhailidis DP; Jeremy JY; Dandona P
    Prostaglandins Leukot Essent Fatty Acids; 1988; 33(3):205-6. PubMed ID: 3070569
    [No Abstract]   [Full Text] [Related]  

  • 44. Role of prostaglandins, prostacyclin, and thromboxanes in the control of prenatal patency and postnatal closure of the ductus arteriosus.
    Coceani F; Olley PM
    Semin Perinatol; 1980 Apr; 4(2):109-13. PubMed ID: 6990501
    [No Abstract]   [Full Text] [Related]  

  • 45. Role of prostaglandins, prostacyclin, and thromboxanes in the control of the umbilical-placental circulation.
    Tuvemo T
    Semin Perinatol; 1980 Apr; 4(2):91-5. PubMed ID: 6990507
    [No Abstract]   [Full Text] [Related]  

  • 46. Cysteinyl-leukotrienes and the liver.
    Farzaneh-Far R; Moore K
    Prostaglandins Other Lipid Mediat; 2003 Oct; 72(1-2):35-50. PubMed ID: 14626495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology].
    Baluda VP; Sushkevich GN; Lukoianova TI
    Patol Fiziol Eksp Ter; 1980; (4):80-5. PubMed ID: 6251418
    [No Abstract]   [Full Text] [Related]  

  • 48. Prostaglandins and leukotrienes.
    Parker CW; Stenson WF
    Curr Opin Immunol; 1989 Oct; 2(1):28-32. PubMed ID: 2514728
    [No Abstract]   [Full Text] [Related]  

  • 49. Role of prostaglandins, prostacyclin, and thromboxanes in the physiologic control of the uterus and in parturition.
    Novy MJ; Liggins GC
    Semin Perinatol; 1980 Jan; 4(1):45-66. PubMed ID: 6770468
    [No Abstract]   [Full Text] [Related]  

  • 50. Liver cytoprotection by prostaglandins.
    Quiroga J; Prieto J
    Pharmacol Ther; 1993; 58(1):67-91. PubMed ID: 8415874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease.
    Hikiji H; Takato T; Shimizu T; Ishii S
    Prog Lipid Res; 2008 Mar; 47(2):107-26. PubMed ID: 18187046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of thromboxane in producing hepatic injury during hepatic stress.
    Yokoyama Y; Nimura Y; Nagino M; Bland KI; Chaudry IH
    Arch Surg; 2005 Aug; 140(8):801-7. PubMed ID: 16103291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Arachidonic acid derivatives and renal function in liver cirrhosis.
    Laffi G; La Villa G; Pinzani M; Marra F; Gentilini P
    Semin Nephrol; 1997 Nov; 17(6):530-48. PubMed ID: 9353864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of prostaglandins and thromboxane in modulation of perfusion pressure in the hydronephrotic rabbit kidney.
    Sivakoff M; Holmberg S; Needleman P
    Adv Prostaglandin Thromboxane Res; 1980; 7():1175-6. PubMed ID: 7369027
    [No Abstract]   [Full Text] [Related]  

  • 55. [Prostanoids (prostaglandins, thromboxanes, prostacyclin) and leukotrienes].
    Kecskeméti V
    Orv Hetil; 1983 Dec; 124(49):2967-74. PubMed ID: 6318174
    [No Abstract]   [Full Text] [Related]  

  • 56. Leukotrienes as mediators in diseases of the liver.
    Keppler D; Huber M; Baumert T
    Semin Liver Dis; 1988 Nov; 8(4):357-66. PubMed ID: 3062791
    [No Abstract]   [Full Text] [Related]  

  • 57. [Prostacyclins and thromboxanes, new substances from the prostanoid group].
    Masek K; Kadlec O
    Cas Lek Cesk; 1980 Jul; 119(29-30):785-7. PubMed ID: 7000358
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pulmonary prostaglandins and leukotrienes].
    Uotila P
    Duodecim; 1984; 100(16):1026-33. PubMed ID: 6510258
    [No Abstract]   [Full Text] [Related]  

  • 59. Prostaglandins and leukotrienes: advances in eicosanoid biology.
    Funk CD
    Science; 2001 Nov; 294(5548):1871-5. PubMed ID: 11729303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glomerular eicosanoids and diabetes mellitus.
    Dunn MJ
    J Lab Clin Med; 1989 Jun; 113(6):659-61. PubMed ID: 2732613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.